Related Experiment Videos

Multiple roles of SOCS proteins: differential expression of SOCS1 and SOCS3 in atherosclerosis

Xiao Liang1, Ming He, Tao Chen

  • 1Department of Cardiovascular Medicine, The First Affiliated Hospital of Medical School, Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China.

Insights

Suppressor of cytokine signaling (SOCS) proteins, SOCS1 and SOCS3, show differential expression in atherosclerosis. SOCS3, along with Interleukin-6 (IL-6), may promote atherosclerosis development, with SOCS3 correlating with cholesterol levels.

Area of Science:

  • Cardiovascular Biology
  • Immunology
  • Molecular Medicine

Background:

  • Pro-inflammatory cytokines are key in atherosclerosis pathogenesis, regulated by the Janus kinase/signal transducer and activator of transduction (JAK/STAT) pathway.
  • Suppressor of cytokine signaling (SOCS) proteins, including SOCS1 and SOCS3, negatively regulate the JAK/STAT pathway.
  • The precise role and expression patterns of SOCS proteins in atherosclerosis remain unclear.

Purpose of the Study:

  • To investigate the differential expression of SOCS1 and SOCS3 in atherosclerosis.
  • To explore the correlation between SOCS expression and cholesterol levels in atherosclerosis.
  • To elucidate the potential role of SOCS proteins in atherosclerosis development.

Main Methods:

  • A mouse model of atherosclerosis was established using apolipoprotein-deficient (ApoE(-/-)) mice fed a chow or high-fat diet.
  • SOCS1 and SOCS3 mRNA and protein expression were analyzed in plaques and vessels at various time points.
  • SOCS1 and SOCS3 mRNA expression was also assessed in peripheral blood mononuclear cells (PBMCs) from a non-coronary heart disease (non-CHD) human population.

Main Results:

  • SOCS1 expression in ApoE(-/-) mice initially increased then decreased, with high-fat diet accelerating this peak.
  • SOCS3 expression increased with feeding duration, particularly in high-fat diet-fed mice, showing a positive correlation with Interleukin-6 (IL-6) in the aorta.
  • In humans, total serum cholesterol positively correlated with SOCS3 mRNA expression in PBMCs.

Conclusions:

  • SOCS1 and SOCS3 exhibit distinct expression patterns during atherosclerosis development.
  • SOCS3, in conjunction with IL-6, may contribute to the promotion of atherosclerosis.
  • These findings highlight SOCS proteins as potential targets for atherosclerosis management.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...